Patents by Inventor Van Tuan NGUYEN

Van Tuan NGUYEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240068783
    Abstract: A method to detect, identify and determine the position of laser points from infrared laser emitters in a firearm training simulation system. The method consists of two steps. This first step combines some common tools such as a camera with a filter switcher and edge and corner detecting algorithms in image processing to provide a fast automatic screen calibrating method. The second step is to detect laser point objects in each frame continuously captured by the camera, and then further process these objects to identify laser shots, filter out noisy objects, and eventually detect simulated shots from different laser emitters and determine the final mapped position of the shot.
    Type: Application
    Filed: July 25, 2023
    Publication date: February 29, 2024
    Applicant: VIETTEL GROUP
    Inventors: Anh Tuan Vu, Duc Thanh Nguyen, Van Duc Ha, Kim Duc Hoang, Thanh Nhon Nguyen, Anh Tra Duong, Tran Nam Nguyen
  • Publication number: 20240070402
    Abstract: The factual event detection method for online news consists of five main steps: Step 1: Preprocess raw text to split a document into sentences and words, find part-of-speech tags (POS tags), and digitize data; Step 2: Encode digitized words and their POS tags into vectors; Step 3: Detect triggers and their event types; Step 4: Concatenate the surrounding encoded vectors of each trigger into an aggregate vector; Step 5: Classify the realis status of each event. The method chosen is used in systems that automatically collect, extract, and analyze data in order to monitor and early warn about the activities of targets mentioned in digital newspapers.
    Type: Application
    Filed: July 25, 2023
    Publication date: February 29, 2024
    Applicant: VIETTEL GROUP
    Inventors: Phat Trien Thai, Van Tuan Nguyen
  • Publication number: 20240040007
    Abstract: The present invention provides a method of finding service endpoints that can be customized. The method includes the following steps: step 1: discover the “services” customized by the CSDE method, called the “services” CSDE; step 2: discover groups of running Pods belonging to the respective CSDE “services”; step 3: register the IP of the Pod to the corresponding CSDE “service” according to the requirement to use a specific network range. The method is deployed to the corresponding CSDE application for installation in a container virtualization environment.
    Type: Application
    Filed: July 5, 2023
    Publication date: February 1, 2024
    Applicant: VIETTEL GROUP
    Inventors: Thanh Tu Pham, Khac Thuan Lang, Van Tuan Nguyen, Ngoc Lam Dao
  • Publication number: 20210271989
    Abstract: The target density prediction method by area comprises of 4 main steps: Step 1: preparing training dataset; Step 2: analyzing time series characteristics of training dataset; Step 3: training the autoregressive integrated moving average model; Step 4: predicting the target density over a defined time period in the future. The chosen method technically analyzes the time series characteristics of historical dataset by monitoring areas, and determines the cycle property, parameters and the autoregressive integrated moving average model to predict the number of targets that have high probability appearing in monitoring area at some point in the future.
    Type: Application
    Filed: December 15, 2020
    Publication date: September 2, 2021
    Applicant: VIETTEL GROUP
    Inventors: Van Tuan Nguyen, Gia Thinh Nguyen, Dinh Bao Khang Nguyen
  • Patent number: 10159684
    Abstract: The present invention relates to method and pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning. In particular, the present invention relates to a mineralocorticoid receptor antagonist for topical use in a method for preventing or reducing glucocorticoid-induced corneal or skin thinning in a subject in need thereof. The invention also relates to a topical pharmaceutical composition comprising an amount of at least one glucocorticoid and an amount of at least one mineralocorticoid receptor antagonist or inhibitor of MR expression for use in a method for treating an inflammatory skin disease or an inflammatory disease of the cornea or of the anterior segment of the eye in a subject in need thereof.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: December 25, 2018
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PARIS DESCARTES, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS (APHP)
    Inventors: Nicolette Farman, Frederic Jaisser, Francine Behar-Cohen, Selin Aractingi, Van Tuan Nguyen
  • Publication number: 20170273992
    Abstract: The present invention relates to method and pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning. In particular, the present invention relates to a mineralocorticoid receptor antagonist for topical use in a method for preventing or reducing glucocorticoid-induced corneal or skin thinning in a subject in need thereof. The invention also relates to a topical pharmaceutical composition comprising an amount of at least one glucocorticoid and an amount of at least one mineralocorticoid receptor antagonist or inhibitor of MR expression for use in a method for treating an inflammatory skin disease or an inflammatory disease of the cornea or of the anterior segment of the eye in a subject in need thereof.
    Type: Application
    Filed: June 8, 2017
    Publication date: September 28, 2017
    Inventors: Nicolette FARMAN, Frederic JAISSER, Francine BEHAR-COHEN, Selin ARACTINGI, Van Tuan NGUYEN
  • Patent number: 9730948
    Abstract: The present invention relates to method and pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning. In particular, the present invention relates to a mineralocorticoid receptor antagonist for topical use in a method for preventing or reducing glucocorticoid-induced corneal or skin thinning in a subject in need thereof. The invention also relates to a topical pharmaceutical composition comprising an amount of at least one glucocorticoid and an amount of at least one mineralocorticoid receptor antagonist or inhibitor of MR expression for use in a method for treating an inflammatory skin disease or an inflammatory disease of the cornea or of the anterior segment of the eye in a subject in need thereof.
    Type: Grant
    Filed: June 20, 2014
    Date of Patent: August 15, 2017
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS DESCARTES, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)
    Inventors: Nicolette Farman, Frederic Jaisser, Francine Behar-Cohen, Selin Aractingi, Van Tuan Nguyen
  • Publication number: 20160136183
    Abstract: The present invention relates to method and pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning. In particular, the present invention relates to a mineralocorticoid receptor antagonist for topical use in a method for preventing or reducing glucocorticoid-induced corneal or skin thinning in a subject in need thereof. The invention also relates to a topical pharmaceutical composition comprising an amount of at least one glucocorticoid and an amount of at least one mineralocorticoid receptor antagonist or inhibitor of MR expression for use in a method for treating an inflammatory skin disease or an inflammatory disease of the cornea or of the anterior segment of the eye in a subject in need thereof.
    Type: Application
    Filed: June 20, 2014
    Publication date: May 19, 2016
    Inventors: Nicolette FARMAN, Frederic JAISSER, Francine BEHAR-COHEN, Selin ARACTINGI, Van Tuan NGUYEN